Compare Unichem Lab with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB DR. REDDYS LAB UNICHEM LAB/
DR. REDDYS LAB
 
P/E (TTM) x -97.7 17.2 - View Chart
P/BV x 0.5 3.3 16.2% View Chart
Dividend Yield % 2.6 0.7 360.6%  

Financials

 UNICHEM LAB   DR. REDDYS LAB
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
DR. REDDYS LAB
Mar-19
UNICHEM LAB/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs2922,875 10.2%   
Low Rs1821,888 9.6%   
Sales per share (Unadj.) Rs167.7930.2 18.0%  
Earnings per share (Unadj.) Rs-3.6117.4 -3.1%  
Cash flow per share (Unadj.) Rs5.9185.8 3.2%  
Dividends per share (Unadj.) Rs4.0020.00 20.0%  
Dividend yield (eoy) %1.70.8 201.0%  
Book value per share (Unadj.) Rs372.3844.4 44.1%  
Shares outstanding (eoy) m70.38166.07 42.4%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x1.42.6 55.2%   
Avg P/E ratio x-65.320.3 -321.8%  
P/CF ratio (eoy) x39.912.8 311.1%  
Price / Book Value ratio x0.62.8 22.6%  
Dividend payout %-110.217.0 -646.8%   
Avg Mkt Cap Rs m16,680395,496 4.2%   
No. of employees `0002.622.0 11.8%   
Total wages/salary Rs m2,39333,562 7.1%   
Avg. sales/employee Rs Th4,535.27,032.8 64.5%   
Avg. wages/employee Rs Th919.81,527.9 60.2%   
Avg. net profit/employee Rs Th-98.2887.7 -11.1%   
INCOME DATA
Net Sales Rs m11,801154,482 7.6%  
Other income Rs m9843,375 29.2%   
Total revenues Rs m12,785157,857 8.1%   
Gross profit Rs m-83531,782 -2.6%  
Depreciation Rs m67411,348 5.9%   
Interest Rs m75889 8.5%   
Profit before tax Rs m-60022,920 -2.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m1438 0.2%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-3433,858 -8.9%   
Profit after tax Rs m-25619,500 -1.3%  
Gross profit margin %-7.120.6 -34.4%  
Effective tax rate %57.316.8 340.3%   
Net profit margin %-2.212.6 -17.2%  
BALANCE SHEET DATA
Current assets Rs m20,384111,101 18.3%   
Current liabilities Rs m5,02958,973 8.5%   
Net working cap to sales %130.133.7 385.6%  
Current ratio x4.11.9 215.1%  
Inventory Days Days10579 132.0%  
Debtors Days Days13594 143.2%  
Net fixed assets Rs m9,023101,245 8.9%   
Share capital Rs m141830 17.0%   
"Free" reserves Rs m26,058139,406 18.7%   
Net worth Rs m26,199140,236 18.7%   
Long term debt Rs m022,000 0.0%   
Total assets Rs m31,496224,656 14.0%  
Interest coverage x-7.026.8 -26.0%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.40.7 54.5%   
Return on assets %-0.69.1 -6.3%  
Return on equity %-1.013.9 -7.0%  
Return on capital %-2.014.9 -13.4%  
Exports to sales %69.40-   
Imports to sales %00-   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,18888,673 9.2%   
Fx outflow Rs m59619,104 3.1%   
Net fx Rs m7,59269,569 10.9%   
CASH FLOW
From Operations Rs m-3,27828,704 -11.4%  
From Investments Rs m-2,860-7,727 37.0%  
From Financial Activity Rs m-24-21,326 0.1%  
Net Cashflow Rs m-4,690-314 1,493.7%  

Share Holding

Indian Promoters % 50.1 25.5 196.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 5.4 279.6%  
FIIs % 3.0 35.3 8.5%  
ADR/GDR % 0.0 18.5 -  
Free float % 31.7 15.3 207.2%  
Shareholders   20,176 75,885 26.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   GSK PHARMA  ASTRAZENECA PHARMA  DISHMAN PHARMA  PIRAMAL ENTERPRISES  JUBILANT LIFE SCIENCES  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Higher; Telecom and Energy Stocks Gain the Most(09:30 am)

Asian share markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.4% while the Hang Seng is down 0.7%.

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Nov 20, 2019 12:11 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS